LXEO Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc. (LXEO) Hedge Fund Activity
This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.
Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.
Most significant moves
Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.
| Fund | Action | Shares changed | Change | Est. value | Portfolio wt. | Score |
|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | Sold Out | -1.68M | -100.0% | $7.8M | 0.0% | 61 |
| RENAISSANCE TECHNOLOGIES LLC Quant | New | +250.4K | — | $1.2M | 0.0% | 60 |
| Suvretta Capital Management Long/Short Growth | Increased | +5.13M | +410.7% | $23.9M | 0.6% | 58 |
| TWO SIGMA INVESTMENTS, LP Quant | Sold Out | -181.7K | -100.0% | $845.7K | 0.0% | 57 |
| Trexquant Investment Quant | New | +314.9K | — | $1.5M | 0.0% | 53 |
| Jain Global Long/Short Quant | New | +16.6K | — | $77.2K | 0.0% | 52 |
| Nantahala Capital Management Event Long/Short | Increased | +1.40M | +116.7% | $6.5M | 0.4% | 51 |
| Walleye Capital Long/Short Quant | New | +73.9K | — | $343.9K | 0.0% | 51 |
| Qube Research & Technologies Ltd Quant | Increased | +910.7K | +195.6% | $4.2M | 0.0% | 51 |
| Schonfeld Strategic Advisors Long/Short Quant | Sold Out | -24.2K | -100.0% | $112.7K | 0.0% | 51 |
Most significant buyers
By move score, not size.
- RENAISSANCE TECHNOLOGIES LLC
- Suvretta Capital Management
- Trexquant Investment
- Jain Global
- Nantahala Capital Management
Most significant sellers
By move score, not size.
- Point72 Asset Management, L.P.
- TWO SIGMA INVESTMENTS, LP
- Schonfeld Strategic Advisors
- Y-Intercept
- Paradigm BioCapital Advisors
Hedge fund positions
| Fund | Tier | Shares | Previous | Change | Change % | Portfolio wt. | Action | Score |
|---|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 1 | 0 | 1.7M | -1.68M | -100.0% | 0.0% | Sold Out | 61 |
| RENAISSANCE TECHNOLOGIES LLC | 1 | 250.4K | 0 | +250.4K | — | 0.0% | New | 60 |
| Suvretta Capital Management | 2 | 6.4M | 1.3M | +5.13M | +410.7% | 0.6% | Increased | 58 |
| TWO SIGMA INVESTMENTS, LP | 2 | 0 | 181.7K | -181.7K | -100.0% | 0.0% | Sold Out | 57 |
| Trexquant Investment | 3 | 314.9K | 0 | +314.9K | — | 0.0% | New | 53 |
| Jain Global | 3 | 16.6K | 0 | +16.6K | — | 0.0% | New | 52 |
| Nantahala Capital Management | 3 | 2.6M | 1.2M | +1.40M | +116.7% | 0.4% | Increased | 51 |
| Walleye Capital | 3 | 73.9K | 0 | +73.9K | — | 0.0% | New | 51 |
| Qube Research & Technologies Ltd | 2 | 1.4M | 465.5K | +910.7K | +195.6% | 0.0% | Increased | 51 |
| Schonfeld Strategic Advisors | 3 | 0 | 24.2K | -24.2K | -100.0% | 0.0% | Sold Out | 51 |
| Y-Intercept | 4 | 0 | 142.6K | -142.6K | -100.0% | 0.0% | Sold Out | 48 |
| MILLENNIUM MANAGEMENT LLC | 2 | 2.8M | 1.6M | +1.22M | +75.7% | 0.0% | Increased | 47 |
| Paradigm BioCapital Advisors | 1 | 4.2M | 6.2M | -2.01M | -32.5% | 0.4% | Reduced | 42 |
| Balyasny Asset Management L.P. | 2 | 2.4M | 1.6M | +823.2K | +51.8% | 0.0% | Increased | 41 |
| ExodusPoint Capital Management | 3 | 27.9K | 112.2K | -84.3K | -75.1% | 0.0% | Reduced | 40 |
| Affinity Asset Advisors | 2 | 5.8M | 5.1M | +757.4K | +15.0% | 1.4% | Increased | 39 |
| Avoro Capital Advisors | 1 | 1.5M | 1.9M | -385.8K | -20.6% | 0.1% | Reduced | 37 |
| D. E. Shaw & Co., Inc. | 1 | 19.9K | 30.5K | -10.6K | -34.8% | 0.0% | Reduced | 35 |
| OrbiMed Advisors | 2 | 3.9M | 3.6M | +345.4K | +9.6% | 0.3% | Increased | 33 |
| Vestal Point Capital | 1 | 4.3M | 4.5M | -155.0K | -3.5% | 0.5% | Reduced | 32 |
| Woodline Partners LP | 2 | 2.5M | 2.8M | -250.0K | -9.1% | 0.0% | Reduced | 28 |
| CITADEL ADVISORS LLC | 1 | 3.9M | 3.8M | +63.6K | +1.7% | 0.0% | Increased | 27 |
| ADAR1 Capital Management | 3 | 1.6M | 1.5M | +98.6K | +6.7% | 0.4% | Increased | 26 |
| AQR Capital Management | 3 | 256.7K | 339.6K | -83.0K | -24.4% | 0.0% | Reduced | 26 |
| Squarepoint Ops LLC | 2 | 294.8K | 319.1K | -24.3K | -7.6% | 0.0% | Reduced | 25 |
| RA Capital Management | 1 | 5.0M | 5.0M | 0 | +0.0% | 0.2% | Unchanged | 27 |
| Boothbay Fund Management | 4 | 136.4K | 136.4K | 0 | +0.0% | 0.0% | Unchanged | 13 |
Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeHedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.